📰 Disease Program News
Page 19 - Disease Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Disease Program. Real-time updates on events, politics, business and more.
February 2, 2023
Compared to other large states, fewer state dollars go to Alzheimer’s disease services in Texas. Now with more national attention on research here, could that change?
November 9, 2022
IDNR announces 2022 chronic wasting disease sampling locations for deer hunters SPRINGFIELD, IL-(Effingham Rad...
November 4, 2022
/PRNewswire/ -- The Gates Biomanufacturing Facility (GBF) has announced the successful completion of the full cycle manufacturing of the recombinant Bulk Drug...
November 2, 2022
LEXEO Therapeutics Bolsters Cardiac Gene Therapy Leadership with New Executive Appointment and Formation of Scientific Advisory Board - read this article along with other careers information, tips and advice on BioSpace
August 6, 2022
You are going to want to avoid having sex in these 5 counties in New Jersey
August 5, 2022
Granted FDA Fast Track Designation for APC Clinical CandidatePublished Comprehensive Preclinical Research on SQZ® TAC Platform in Frontiers in ImmunologyPresented First SQZ® Point-of-Care (POC) Manufacturing System Performance Data; Initial Clinical Use Planned for SQZ® TAC Celiac Disease Program with IND Submission...
August 2, 2022
You are going to want to avoid having sex in these 5 counties in New Jersey
August 1, 2022
Rare diagnosis points to need for thorough workup in patients with severe nasal congestion
June 10, 2022
A new analysis led by researchers with the University of California has found the top threats to Americans today regarding dementia in old age are obesity, physical inactivity, and lack of a high school diploma.
April 12, 2022
The Leona M. and Harry B. Helmsley Charitable Trust awarded the funds to expand its support of the Stenosis Therapy and Anti-Fibrotic Research (STAR) consortium for the development of biomarker tools for intestinal fibrosis in patients with Crohn's disease.